GH News and Press, Guardant Health Inc. From 12/11/23

2023-12-11 00:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Mission-focused collaboration to explore opportunities to help accelerate the discovery and development of cancer drugs and diagnostics for patients Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizo...

Spotlight sessions highlight role of Guardant blood tests in tissue-free detection of minimal residual disease and predictive impact of ctDNA genomic profiling MRD study found ctDNA detection after adjuvant therapy using Guardant Reveal ™ was prognostic for distant recurrence o...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on November 8, 2023, the Compensation Committee of Guardant’s Board of Directors granted restricted stock units (“RSUs”) representing 50,741 shares of its common stock to 43 new non...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it intends to appeal yesterday’s verdict in the U.S. District Court for the District of Delaware related to intellectual property claims brought against Guardant by TwinStrand Biosciences, Inc. and Un...

Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / November 14, 2023 / Gamehost Inc. (TSX:GH) Management and Directors of Gamehost Inc. (the "Company") present results for the nine and three months ended September 30, 2023 (th...

2023-11-13 12:51:16 ET More on Guardant Health Guardant Health, Inc. (GH) Q3 2023 Earnings Call Transcript Guardant Health, Inc. 2023 Q3 - Results - Earnings Call Presentation Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified ...

2023-11-06 20:53:02 ET Guardant Health, Inc. (GH) Q3 2023 Earnings Conference Call November 06, 2023, 04:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-CEO AmirAli Talasaz - Co-CEO Michael Bell - CFO Conference Call Participants ...

2023-11-06 16:15:03 ET More on Guardant Health Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more Guardant Health Q3 2023 Earnings Preview Seekin...

Q3 revenue increased 22% year over year driven by clinical volume growth of 35% Raises 2023 revenue guidance to $553 to 556 million Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary ...